المؤلفون: Xia Si, Hongyan Zhang, Qingming Ding, Gang Liu, Lin Huang, Xin Sun

المصدر: Cancer Medicine, Vol 13, Iss 6, Pp n/a-n/a (2024)

مصطلحات موضوعية: antiemetic, cisplatin‐based chemotherapy, nausea, prescribing, vomiting, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2045-7634Test

الوصول الحر: https://doaj.org/article/f182e64fea1e4dae914042a9a3745677Test

المؤلفون: Mohammad Jad Moussa, Matthew T. Campbell, Omar Alhalabi

المصدر: Biomedicines, Vol 12, Iss 3, p 519 (2024)

مصطلحات موضوعية: metastatic urothelial cancer, cisplatin-based chemotherapy, platinum-based chemotherapy, cisplatin ineligible, platinum ineligible, enfortumab vedotin, Biology (General), QH301-705.5

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2227-9059/12/3/519Test; https://doaj.org/toc/2227-9059Test

الوصول الحر: https://doaj.org/article/377a74046c09489887e9cdd18dbe7230Test

المؤلفون: Chunkai Du, Mengmeng Zheng, Zhipeng Wang, Jian Zhang, Jun Lin, Lei Zhang, Ye Tian, Yichen Zhu

المصدر: BMC Urology, Vol 23, Iss 1, Pp 1-7 (2023)

مصطلحات موضوعية: Kidney transplantation, Urothelial carcinoma, Cisplatin-based chemotherapy, Bladder infusion chemotherapy, Rapamycin, Clinical prognosis, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/1471-2490Test

الوصول الحر: https://doaj.org/article/45e751bd4c154e54ac7b2d752877c266Test

المؤلفون: Culine, Stéphane, Harter, Valentin, Krucker, Clémentine, Gravis, Gwénaëlle, Fléchon, Aude, Chevreau, Christine, Mahammedi, Hakim, Laguerre, Brigitte, Guillot, Aline, Joly, Florence, Fontugne, Jacqueline, Allory, Yves, Pfister, Christian

المساهمون: Hopital Saint-Louis AP-HP (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Centre Régional de Lutte contre le Cancer François Baclesse Caen (UNICANCER/CRLC), Normandie Université (NU)-UNICANCER-Tumorothèque de Caen Basse-Normandie (TCBN), Biologie Cellulaire et Cancer, Institut Curie Paris -Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Département cancer environnement (Centre Léon Bérard - Lyon), Centre Léon Bérard Lyon, Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Jean Perrin Clermont-Ferrand (UNICANCER/CJP), UNICANCER, CRLCC Eugène Marquis (CRLCC), Institut de Cancérologie Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E), Institut Lavoisier de Versailles (ILV), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Institut Curie Paris, Hôpital Charles Nicolle Rouen, CHU Rouen, Normandie Université (NU)-Normandie Université (NU), Ministère des Affaires Sociales et de la Santé, (PHRC 2011-037), Institut National Du Cancer, INCa

المصدر: ISSN: 2072-6694.

مصطلحات موضوعية: cisplatin-based chemotherapy, muscle-invasive bladder cancer, neoadjuvant treatment, pathological complete response, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and Nephrology, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

العلاقة: hal-04195179; https://hal.science/hal-04195179Test; https://hal.science/hal-04195179/documentTest; https://hal.science/hal-04195179/file/cancers-15-01742.pdfTest

الإتاحة: https://doi.org/10.3390/cancers15061742Test
https://hal.science/hal-04195179Test
https://hal.science/hal-04195179/documentTest
https://hal.science/hal-04195179/file/cancers-15-01742.pdfTest

المؤلفون: Konstantinos Evmorfopoulos, Lampros Mitrakas, Athanasios Karathanasis, Ioannis Zachos, Vassilios Tzortzis, Panagiotis J. Vlachostergios

المصدر: Biomedicines; Volume 11; Issue 7; Pages: 1775

مصطلحات موضوعية: upper tract urothelial carcinoma, cisplatin-based chemotherapy, FGFR3, luminal papillary, T-cell depleted, immune checkpoint inhibitors, lynch syndrome, radical nephroureterectomy

وصف الملف: application/pdf

العلاقة: Cancer Biology and Therapeutics; https://dx.doi.org/10.3390/biomedicines11071775Test

الإتاحة: https://doi.org/10.3390/biomedicines11071775Test

المؤلفون: Stéphane Culine, Valentin Harter, Clémentine Krucker, Gwenaelle Gravis, Aude Fléchon, Christine Chevreau, Hakim Mahammedi, Brigitte Laguerre, Aline Guillot, Florence Joly, Jacqueline Fontugne, Yves Allory, Christian Pfister

المصدر: Cancers; Volume 15; Issue 6; Pages: 1742

مصطلحات موضوعية: muscle-invasive bladder cancer, cisplatin-based chemotherapy, neoadjuvant treatment, pathological complete response

وصف الملف: application/pdf

العلاقة: https://dx.doi.org/10.3390/cancers15061742Test

الإتاحة: https://doi.org/10.3390/cancers15061742Test

المؤلفون: Shunsuke Owa, Takeshi Sasaki, Katsunori Uchida, Susumu Watanabe, Momoko Kato, Yusuke Sugino, Manabu Kato, Satoru Masui, Kouhei Nishikawa, Yuko Yoshio, Hideki Kanda, Yoshiki Sugimura, Takahiro Inoue

المصدر: IJU Case Reports, Vol 4, Iss 5, Pp 267-271 (2021)

مصطلحات موضوعية: adenocarcinoma of the rete testis, cisplatin‐based chemotherapy, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

العلاقة: https://doaj.org/toc/2577-171XTest

الوصول الحر: https://doaj.org/article/75fb9d205e2b4d6c8281e1d48d678e8fTest

المؤلفون: Pal, Sumanta K, Somford, Diederik M, Grivas, Petros, Sridhar, Srikala S, Gupta, Shilpa, Bellmunt, Joaquim, Sonpavde, Guru, Fleming, Mark T, Lerner, Seth P, Loriot, Yohann, Hoffman-Censits, Jean, Valderrama, Begoña P, Andresen, Corina, Schnabel, Marco J, Cole, Suzanne, Daneshmand, Siamak

مصطلحات موضوعية: FGFR inhibitor, FGFR3, PROOF 302, adjuvant cisplatin-based chemotherapy, adjuvant therapy, cisplatin-therapy refusal, fusions or rearrangements, infigratinib, muscle-invasive urothelial carcinoma, mutations, neoadjuvant cisplatin-based chemotherapy, phase III, upper tract urothelial carcinoma, urothelial bladder carcinoma, urothelial carcinoma, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Transitional Cell, Chemotherapy, Adjuvant, Humans, Phenylurea Compounds, Pyrimidines, Randomized Controlled Trials as Topic, Receptor, Fibroblast Growth Factor, Type 3, Urinary Bladder Neoplasms

العلاقة: http://hdl.handle.net/10668/20492Test; https://doi.org/10.2217/fon-2021-1629Test

الإتاحة: https://doi.org/10.2217/fon-2021-1629Test
http://hdl.handle.net/10668/20492Test

المؤلفون: Matteo Ferro, Ottavio de Cobelli, Gennaro Musi, Giuseppe Lucarelli, Daniela Terracciano, Daniela Pacella, Tommaso Muto, Angelo Porreca, Gian Maria Busetto, Francesco Del Giudice, Francesco Soria, Paolo Gontero, Francesco Cantiello, Rocco Damiano, Fabio Crocerossa, Abdal Rahman Abu Farhan, Riccardo Autorino, Mihai Dorin Vartolomei, Matteo Muto, Michele Marchioni, Andrea Mari, Luca Scafuri, Andrea Minervini, Nicola Longo, Francesco Chiancone, Sisto Perdona, Pietro De Placido, Antonio Verde, Michele Catellani, Stefano Luzzago, Francesco Alessandro Mistretta, Pasquale Ditonno, Vincenzo Francesco Caputo, Michele Battaglia, Stefania Zamboni, Alessandro Antonelli, Francesco Greco, Giorgio Ivan Russo, Rodolfo Hurle, Nicolae Crisan, Matteo Manfredi, Francesco Porpiglia, Giuseppe Di Lorenzo, Felice Crocetto, Carlo Buonerba

المصدر: Frontiers in Oncology, Vol 11 (2021)

مصطلحات موضوعية: bladder cancer, neoadjuvant chemotherapy, radical cystectomy, observational study, cisplatin-based chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fonc.2021.651745/fullTest; https://doaj.org/toc/2234-943XTest

الوصول الحر: https://doaj.org/article/2ba37d713d7a40cb85bfb53ae5a8709fTest

المؤلفون: Sumanta K Pal, Diederik M Somford, Petros Grivas, Srikala S Sridhar, Shilpa Gupta, Joaquim Bellmunt, Guru Sonpavde, Mark T Fleming, Seth P Lerner, Yohann Loriot, Jean Hoffman-Censits, Begoña P Valderrama, Corina Andresen, Marco J Schnabel, Suzanne Cole, Siamak Daneshmand

المصدر: Future Oncology. 18:2599-2614

مصطلحات موضوعية: adjuvant cisplatin-based chemotherapy, Cancer Research, Adjuvant therapy, infigratinib, Urothelial bladder carcinoma, Phase III, Antineoplastic Combined Chemotherapy Protocols, urothelial bladder carcinoma, Cisplatin-therapy refusal, Humans, Receptor, Fibroblast Growth Factor, Type 3, neoadjuvant cisplatin-based chemotherapy, Fusions or rearrangements, urothelial carcinoma, Randomized Controlled Trials as Topic, cisplatin-therapy refusal, Infigratinib, Carcinoma, Transitional Cell, Phenylurea Compounds, Adjuvant cisplatin-based chemotherapy, muscle-invasive urothelial carcinoma, adjuvant therapy, General Medicine, PROOF 302, mutations, upper tract urothelial carcinoma, Muscle-invasive urothelial carcinoma, phase III, FGFR inhibitor, fusions or rearrangements, Pyrimidines, Urinary Bladder Neoplasms, Oncology, Chemotherapy, Adjuvant, FGFR3, Upper tract urothelial carcinoma, Urothelial carcinoma, Mutations, Neoadjuvant cisplatin-based chemotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5433e695165452027d0ac448f2826777Test
https://doi.org/10.2217/fon-2021-1629Test